Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2224PDF: 2058HTML: 199 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1789PDF: 1182HTML: 253 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
995PDF: 542HTML: 729 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3749PDF: 1476HTML: 188 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1738PDF: 1109HTML: 10706Untitled: 195 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1421PDF: 827HTML: 8664Fig 3 Savini: 178Fig 2 Savini: 186Fig 1 Savini Chest TC: 191Author letter to referees: 191 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1218PDF: 797HTML: 223 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
960PDF: 524HTML: 215 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1875PDF: 729HTML: 2119Untitled: 225Untitled: 158Untitled: 177Untitled: 161Untitled: 169Untitled: 184Untitled: 191 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1651PDF: 807HTML: 867jdoe, table 2 infections CML .doc: 201jdoe, table 1 infections CML .doc: 187 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3609PDF: 1518HTML: 4424CoverLetter: 189Figure1: 202 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1805PDF: 697HTML: 2417Untitled: 161Figure 1 a: 167Figure 1 b: 177Fig 1 c: 160Figure 1 d: 206 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2781PDF: 980HTML: 4709







